J. Thomas Vaughan, PhD

System Development, Image
Creation, Bio-Medical
Engineering

Dr. Vaughan is Director of the Columbia Magnetic Resonance Research Center and Professor of Biomedical Engineering and Radiology at Columbia University. He received a PhD in Biomedical Engineering from University of Alabama at Birmingham and a B.S. in Biology and a B.S. in Electrical Engineering from Auburn University. Prior to joining the faculty at Columbia University in 2016, Tommy was Professor of Radiology, Biomedical Engineering, and Electrical and Computer Engineering at the University of Minnesota where he held the Quist-Henline Chair in Biomedical Research. Minnesota recruited him from Boston where he was Assistant Professor of Radiology at Harvard Medical School and was Assistant in Physics and Director Engineering at the MGH NMR (Martinos) Center . He holds 56 patents related to the science and engineering of magnetic resonance imaging. He is a Fellow of the Institute of Electrical and Electronics Engineers (IEEE), Fellow of the American Institute for Medical and Biological Engineering (AIMBE), Fellow of the International Society for Magnetic Resonance in Medicine (ISMRM), Senior Member of the Radiological Society of North America, Member Biomedical Engineering Society (BMES) and is recorded in 150 academic articles.

R. Gilberto González, MD, PhD

Clinical, Radiology, AI Diagnostics
Protocols & Applications

Dr. González is Professor and Associate Chief, Imaging Sciences Director of Translational AI Research and Chief of Neuroradiology Emeritus at the Massachusetts General Hospital and Harvard Medical School. He received his MD from Harvard Medical School and a PhD in biophysical chemistry from the University of California, Santa Cruz. He did post-doctoral work in molecular biophysics at the Francis Bitter National Magnet Lab at MIT. His clinical training included an internship in medicine and a residency in radiology at the Brigham and Women's Hospital, and a neuroradiology fellowship at the MGH. Since 1989 he has practiced at the MGH and has been on the faculty at Harvard.

Robert Todd Constable, PhD

Co-Founder
System Development & MR Physics

Dr. Constable is the Director of MRI research in the Yale Magnetic Resonance Research Center and a Professor of Radiology and Biomedical Imaging, Biomedical Engineering, & Neurosurgery at Yale University where he has worked for the past 31 years. He received his PhD in Medical Biophysics from the University of Toronto, M.S. in Medical Physics from the University of Manitoba, and B.S. in Physics from the University of Winnipeg. Todd holds eleven patents related to the development of improved magnetic resonance image systems, acquisition strategies, and image reconstruction. He has over 310 peer reviewed publications related to the development and application of new MRI methods. He is a Fellow of the International Society of Magnetic Resonance in Medicine and the American College of Radiology.

Sairam Geethanath, PhD

Co-Founder
System Software Developer

Dr. Geethanath is an Associate Professor of Biomedical Engineering and Imaging Institute-- Department of Diagnostic, Molecular and Interventional Radiology--at the Mount Sinai School of Medicine. He received a PhD in Biomedical Engineering from the University of Texas, Arlington/Southwest Medical Center, M.S. in Electrical Engineering from the Illinois Institute of Technology, and B.E. in Instrumentation from Visvesvaraya Technological University. Prior to joining the faculty at Columbia University in 2018, Sairam was Head, Medical Electronics Department and Director, Biomedical Research Centre at Dayananda Sagar Institutions, Research Associate, Imaging Physics and Engineering at Imperial College of London.

Chris Rose, M.S.

Chief Executive Officer

Mr. Rose was President, Brunsfield America, a subsidiary of Brunsfield International Group headquartered in Kuala Lumpur, Malaysia from 2020 to 2021 and Executive Vice President from 2015 to 2020. He was responsible for U.S. operations and global real estate and healthcare partnership investments. He also led global engagement efforts for a 380,000-acre city-scale development project in Malaysia. Prior to joining Brunsfield in 2015, Mr. Rose was Senior Vice President at Marriott International. During his 27-year career at Marriott International, he was responsible for the development of all Marriott’s full-service and luxury brands for the Western-half of the U.S., development of Marriott’s select-service brands for Southwest U.S. and held positions in market planning and feasibility and corporate tax. Mr. Rose received an M.S. in Tourism/Real Estate, with a concentration in Finance, from the University of Wisconsin-Stout and a B.S. in Economics from the University of Wisconsin-Madison.

Jitesh Shetty, MS

Co-Founder and Director

Mr. Shetty was a Co-Founder of Qwiklabs and led Google Cloud Learning Technologies through January 2022 after Alphabet acquired Qwiklabs in 2016. He also co-founded InfiniChains in 2018. From 2017 to 2018, Jitesh was a Limited Partner in Twin Ventures, Founding Investor in Suspect Technologies, Investor in Avoma, and an Advisor for CapitalG. He founded Fruition IT Solutions LLC in 2007. He has been a Non-Executive Independent Director of ECU Worldwide since August 2021. Jitesh received an M.S. in Computer Science from the University of California and a Bachelor of Engineering and Computer Science from Shri Guru Gobind Singhji Institute of Engineering and Technology

Greg Sieczkiewicz, JD, PhD

CO-Founder General Counsel
IP Law

Dr. Sieczkiewicz is Founder, Picket Fence Intellectual Property LLC and Executive Partner & Chief IP Counsel, MPM Capital. He serves as Chief IP Counsel for several MPM portfolio companies including iTeos Therapeutics, TCR² Therapeutics, Trieza Therapeutics and Werewolf Therapeutics. Dr. Sieczkiewicz has served the IP strategy architect for more than a dozen venture-backed life sciences companies across the spectrum. He has served as Vice President, IP at Flagship Ventures, and also practiced patent counseling and enforcement at national law firms Mintz Levin, Proskauer Rose and Foley Hoag. Greg is a member of the bar of the Commonwealth of Massachusetts and is admitted to practice before the U.S. Patent and Trademark Office. He is also the former President of the Boston Patent Law Association. Greg received his J.D., magna cum laude, from the evening program of Suffolk University Law School and earned his Ph.D. in Cell, Molecular and Developmental Biology from Tufts University School of Medicine and completed his post-doctoral fellowship at the National Cancer Institute. He received his A.B. in Biology from the College of the Holy Cross.

Chris Collier

Advisor
Strategy, Finance,
Manufacturing

Chris Collier is an Advisor to MRA. Previously, Mr. Collier was the Chief Financial Officer at Flex, a Fortune Global 500 company, which delivers technology innovation, supply chain, and manufacturing solutions to diverse industries and end-markets through its global footprint with 160,000 employees at more than 100 sites in over 30 countries. Mr. Collier spent nearly 25 years at Flex, serving as Chief Accounting Officer and then from 2013 through 2020 as Chief Financial Officer. In addition, he led the corporate strategy organization for several years while CFO. He has overseen the raising of over $18 billion in the debt and equity capital markets, the acquisition of more than 100 companies for an aggregate purchase price of nearly $16 billion, and the sale of numerous companies with a combined value of over $5.5 billion. Mr. Collier was central to the Company’s sound governance practices and risk management, as he led the establishment of Flex’s Enterprise Risk Management program. Mr. Collier helped position Flex to achieve higher margins, consistent earnings, and strong free cash flow generation during his tenure. Mr. Collier holds a bachelor’s degree in accounting from the State University of New York at Buffalo. He previously worked for KPMG and is a certified public accountant. Additionally, he serves as an executive board advisor to various private companies.

Harjinder Bajwa

Advisor
Manufacturing and Supply
Chain, Operations

Mr.Bajwa is COO of Reconext, a leading provider of aftermarket lifecycle services for electronics, serves leading manufacturers, operators, retailers, insurers, data centers and large corporations. Mr. Bajwa spent nearly 10 years at Flex, serving as Senior Vice President , Global Operations. His responsibilities included management of operations, product development & engineering, program management, and facilities for 20+ global manufacturing sites in the medical, automotive, A&D, and mechanicals industries. Mr. Bajwa was also responsible for supply chain management for 300 customers with 5,000 suppliers. Mr. Bajwa received a B.S. in Mechanical Engineering from Panjab University in India and an M.S. in Engineering from San Jose State University.

Pooja Shetty, M.S., MBA

Vice President
Global Business Development

Ms. Shetty was a Senior Manager and Associate Director of Gilead Sciences from 2017 until February 2022. She was a Marketing Manager for Amgen from 2015 to 2016 and Global Marketing Manager responsible for Oncology from 2016 to 2017, where she led the repositioning of a $600 MM product indicated for Multiple Myeloma. Pooja was a Senior Biopharmaceutical Sales Representative for Enbrel from 2014 to 2015. She was an Associate with Leerink Swann Strategic Advisors, an investment bank and consulting firm focused on life sciences from 2010 to 2012, and an Analyst from 2007 to 2009. Pooja received an MBA from the Kellogg School of Management with concentrations in Health Enterprise Management & Marketing, an M.S. in Biotechnology and Molecular Biology from the University of Pennsylvania, and a Bachelor of Technology, Pharmaceuticals and Fine Chemicals from the Institute of Chemical Technology.

Roy Herberger, PhD

Special Advisor
Strategy & Corporate Governance

Dr. Herberger was President of the Thunderbird School of Global Management from 1989-2004. Prior to leading Thunderbird, he was Dean of the Edwin L. Cox School of Business at Southern Methodist University and Associate Dean of the Graduate School of Business, University of Southern California. Roy is Trustee Emeritus of the Mayo Clinic Board of Trustees, following serving as a Trustee from 2006 to 2018. He served as a Director on the Board of Directors for Pinnacle West Corporation from 1992 to 2018. From 2007 to 2019, he was a Director on the Board of Directors for Apollo Education Group and was Lead Independent Director from 2015 to 2019. Roy received a PhD in Business Management from the University of Colorado and an M.S. and B.B.A. in Business Administration from the University of Texas- Austin.

Michela Tosetti, PhD

Advisor
MR System Development

Dr. Tosetti is a faculty member and Senior Physicist at the IRCCS Fondazione Stella Maris in Italy since 1997 and Professor of Magnetic Resonance Physics at Pisa University since 2011. Michela has been the Coordinator of technical-scientific activities for the Pisa Research Foundation since 2012. She is a Director of the UOC Laboratory of Medical Physics and Biotechnology of Magnetic Resonance and a Member of the Scientific Committee of Research Foundation. Michela received a PhD in Physics from the University of Turin and a B.S. in Physics from the University of Pisa. She was a Resident in Health Physics at Pisa Hospital and earned a Postgraduate Diploma in Physics from the University of Pisa.

Richard Fritschi

Special Advisor
Strategy & Manufacturing

Mr. Richard Fritschi has extensive experience leading healthcare companies with over25 years in the medtech industry and over 15 years in the pharma/biotech industry. From 2006 until 2011, Mr. Fritschi was CEO of Ypsomed AG, a global leader for injection devices with 1,200 employees at the time. From 1991 – 2005, Mr. Fritschi held various top management positions at the same orthopedic company after ZIMMER acquired CENTERPULSE. At Zimmer between 2003 - 2005, Mr. Fritschi was President Europe/Australasia. From 2001 - 2003 he was the President of Orthopedics Division – Europe/Asia/Latin America at Centerpulse Ltd and before he was the General Manager, responsible for worldwide sales for the Joint and Fracture Care business at Sulzer Orthopedics Ltd. His career started in 1991 as financial controller and before the global sales responsibility he was divisional CFO. He was for more than 10 years a board member of the Swiss Medtech association and serves today on numerous boards of directors in public and private companies. Mr. Fritschi holds a advanced degree from Harvard Business School (The General Manager) and degrees in Economics and Controlling at the Swiss Institute for Economy in Zürich.

Ruchi Parekh

Co-Founder and COO

Dr. Parekh was the Director of Scientific Operations at HHMI/Janelia which she joined in 2016 as a manager to build a team for their connectomics program. As a postdoctoral researcher (2010-2015) she led a data-sharing pilot in academia (NeuroMorpho.Org) where she built, and scaled up an online database of light microscopy data acquired by scientists around the world. For her doctoral dissertation (2005-2010), she studied interactions between inhibitory and excitatory neurons in the rat hippocampus during in vitro seizure activity to identify potential targets for therapeutic interventions. Ruchi earned her M.B.A. in Entrepreneurship from University of Massachusetts-Amherst, Ph.D. in Neuroscience from The Pennsylvania State University, and her B.A. in Psychology from Ohio Wesleyan University.